Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Recent advances in incretin-based pharmacotherapies for the treatment of obesity and diabetes
Serum uric acid change in relation to antihypertensive therapy with the dihydropyridine calcium channel blockers
Those are useful, but there are serious limitations regarding how benefits to animals can be translated to benefits to people
Deficiencies are less common in developed countries but can occur in people with restrictive diets, alcoholism, or malabsorption
US$ 26.51
US$ 21.47
US$ 29.94
US$ 20.45
US$ 24.17
US$ 24.19
US$ 21.78
US$ 25.71
